Credit Suisse’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-164,035
| Closed | -$673K | – | 4576 |
|
|
2022
Q1 | $673K | Buy |
164,035
+8,564
| +6% | +$35.1K | ﹤0.01% | 2788 |
|
|
2021
Q4 | $556K | Sell |
155,471
-7,906
| -5% | -$28.3K | ﹤0.01% | 2956 |
|
|
2021
Q3 | $595K | Buy |
163,377
+7,120
| +5% | +$25.9K | ﹤0.01% | 2899 |
|
|
2021
Q2 | $682K | Buy |
156,257
+23,510
| +18% | +$103K | ﹤0.01% | 2853 |
|
|
2021
Q1 | $546K | Sell |
132,747
-53,505
| -29% | -$220K | ﹤0.01% | 2898 |
|
|
2020
Q4 | $743K | Buy |
186,252
+49,732
| +36% | +$198K | ﹤0.01% | 2763 |
|
|
2020
Q3 | $368K | Buy |
136,520
+15,995
| +13% | +$43.1K | ﹤0.01% | 2813 |
|
|
2020
Q2 | $331K | Buy |
120,525
+39,101
| +48% | +$107K | ﹤0.01% | 2900 |
|
|
2020
Q1 | $193K | Sell |
81,424
-40,778
| -33% | -$96.7K | ﹤0.01% | 3052 |
|
|
2019
Q4 | $574K | Buy |
122,202
+36,561
| +43% | +$172K | ﹤0.01% | 2840 |
|
|
2019
Q3 | $286K | Sell |
85,641
-17,457
| -17% | -$58.3K | ﹤0.01% | 3060 |
|
|
2019
Q2 | $340K | Buy |
103,098
+22,378
| +28% | +$73.8K | ﹤0.01% | 2985 |
|
|
2019
Q1 | $246K | Buy |
80,720
+6,684
| +9% | +$20.4K | ﹤0.01% | 3109 |
|
|
2018
Q4 | $201K | Buy |
+74,036
| New | +$201K | ﹤0.01% | 3137 |
|
|
2018
Q3 | – | Sell |
-37,436
| Closed | -$96K | – | 3480 |
|
|
2018
Q2 | $96K | Sell |
37,436
-12,981
| -26% | -$33.3K | ﹤0.01% | 3378 |
|
|
2018
Q1 | $111K | Buy |
50,417
+8,984
| +22% | +$19.8K | ﹤0.01% | 3362 |
|
|
2017
Q4 | $82K | Sell |
41,433
-52,608
| -56% | -$104K | ﹤0.01% | 3362 |
|
|
2017
Q3 | $305K | Buy |
94,041
+63,597
| +209% | +$206K | ﹤0.01% | 3255 |
|
|
2017
Q2 | $99K | Sell |
30,444
-21,088
| -41% | -$68.6K | ﹤0.01% | 3330 |
|
|
2017
Q1 | $146K | Buy |
+51,532
| New | +$146K | ﹤0.01% | 3288 |
|
|
2016
Q3 | – | Sell |
-537,318
| Closed | -$565K | – | 3886 |
|
|
2016
Q2 | $565K | Buy |
537,318
+515,478
| +2,360% | +$542K | ﹤0.01% | 3048 |
|
|
2016
Q1 | $19K | Sell |
21,840
-12,105
| -36% | -$10.5K | ﹤0.01% | 3626 |
|
|
2015
Q4 | $41K | Sell |
33,945
-59,770
| -64% | -$72.2K | ﹤0.01% | 3915 |
|
|
2015
Q3 | $159K | Sell |
93,715
-59,189
| -39% | -$100K | ﹤0.01% | 3787 |
|
|
2015
Q2 | $318K | Buy |
152,904
+107,492
| +237% | +$224K | ﹤0.01% | 3709 |
|
|
2015
Q1 | $122K | Sell |
45,412
-48,797
| -52% | -$131K | ﹤0.01% | 3912 |
|
|
2014
Q4 | $242K | Buy |
94,209
+40,788
| +76% | +$105K | ﹤0.01% | 3815 |
|
|
2014
Q3 | $98K | Sell |
53,421
-170,188
| -76% | -$312K | ﹤0.01% | 3898 |
|
|
2014
Q2 | $599K | Buy |
223,609
+44,970
| +25% | +$120K | ﹤0.01% | 3282 |
|
|
2014
Q1 | $625K | Buy |
178,639
+43,873
| +33% | +$153K | ﹤0.01% | 3181 |
|
|
2013
Q4 | $603K | Buy |
134,766
+6,271
| +5% | +$28.1K | ﹤0.01% | 3239 |
|
|
2013
Q3 | $522K | Buy |
128,495
+99,107
| +337% | +$403K | ﹤0.01% | 3058 |
|
|
2013
Q2 | $122K | Buy |
+29,388
| New | +$122K | ﹤0.01% | 3579 |
|